Last reviewed: July 9, 2026
Last updated: July 9, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide treatment begins with a .25mg dose designed to allow your body to adapt to GLP-1 receptor activation while minimizing adjustment side effects. This initial phase is not meant to be permanent—it is a launching point that typically lasts exactly four weeks before your provider evaluates your response and adjusts your dose accordingly.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
Understanding the .25mg Starting Dose Timeline
The .25mg dose is a medically established introduction phase recognized across weight loss and diabetes treatment protocols. This dose level activates GLP-1 receptors in your brain and gut at a level your system can tolerate while you develop familiarity with weekly injections and initial appetite suppression signals. Most patients remain on this dose for exactly four weeks—one injection per week for four consecutive injections—before moving forward.
During week one through week four, your body begins responding to semaglutide's mechanism: slowing gastric emptying, enhancing feelings of fullness, and reducing hunger signaling in appetite centers. You may notice reduced food cravings or earlier satiety during meals, though the metabolic impact at this dose level is modest compared to higher therapeutic doses. Keeping a food and symptom log during this initial phase helps your PlexusDx provider identify how your individual physiology is responding.
The Dose Escalation Schedule After Week Four
After your fourth weekly injection of the .25mg dose, the standard protocol moves you to .5mg for the following four weeks. This stepwise increase, called titration, mirrors the approach used in FDA-supervised semaglutide trials and reduces the likelihood of gastrointestinal side effects while building toward your therapeutic dose. PlexusDx follows this evidence-based escalation pathway: weeks 1–4 at .25mg, weeks 5–8 at .5mg, weeks 9–12 at 1mg, and weeks 13+ potentially reaching 2.4mg depending on your response and tolerance.
The reason for this gradual escalation is physiological: your GLP-1 receptors become increasingly sensitive to the medication as your body adjusts, and your gut develops tolerance to dose-dependent nausea or constipation. Jumping directly to higher doses increases dropout rates due to side effects without improving long-term weight loss outcomes. Your dose may need to go up. Your price won't—PlexusDx charges a flat monthly rate regardless of which dose level you are currently using.
How Long You Stay on Semaglutide Overall
While the .25mg phase lasts four weeks, the entire semaglutide treatment course is typically ongoing and long-term. Clinical evidence shows that weight loss continues to improve as you progress through the dose escalation schedule, with maximum effects generally observed at doses of 1.0mg and above over 12–24 weeks of continuous treatment. Stopping semaglutide usually results in weight regain, meaning most patients continue treatment for 6–12 months or longer to sustain results.
PlexusDx serves patients across all 50 states without requiring insurance or monthly membership fees, making long-term access straightforward. Compounded Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan across all dose levels, ensuring your financial commitment remains predictable as your clinical dose advances. Your provider will reassess your goals, side effect profile, and weight loss progress every 4 weeks and determine whether to continue escalating, maintain your current dose, or adjust your treatment plan.
Individual Variation: Why Your Timeline May Differ
Not every patient follows the identical four-week dose-escalation schedule. Some individuals experience significant appetite suppression or side effects at .25mg and may remain on that dose for 8 weeks before advancing, while others tolerate the protocol exactly as outlined and move to .5mg on schedule. Your baseline metabolic rate, prior weight loss attempts, genetics, concurrent medications, and gastrointestinal sensitivity all influence how quickly your provider adjusts your dose.
The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
Exactly how many weeks do I take the .25mg dose of semaglutide?
The .25mg dose is typically prescribed for four weeks—exactly one injection per week for four consecutive weeks. At week five, your PlexusDx provider will reassess your tolerance and response, then move you forward to the next dose level (.5mg) in the standard escalation sequence unless clinical reasons warrant a different approach.
Why does semaglutide start so low if the maximum dose is 2.4mg?
Starting at .25mg mirrors the approach validated in clinical trials because gradual dose escalation reduces nausea and gastrointestinal side effects while achieving the same long-term weight loss outcomes as rapid increases. Your body's GLP-1 receptors adapt over weeks, making higher doses increasingly tolerable and effective. This strategy maximizes treatment completion rates and sustainable weight loss.
Will my cost increase when my semaglutide dose goes up from .25mg to .5mg?
No. PlexusDx charges a flat monthly rate for Compounded Semaglutide Injection at $189/mo month-to-month, or from $149/mo on the 6-month plan, with no flat per-compound pricing tiers. Your dose may need to go up. Your price won't. You maintain the same monthly fee whether you are on week one at .25mg or week twenty at 2.4mg.
Is it safe to stay on the .25mg dose if it is working for my weight loss?
While some patients experience early weight loss at .25mg, clinical evidence shows that continuing to your therapeutic dose level produces significantly greater total weight loss. Your PlexusDx provider will discuss whether escalating aligns with your goals and tolerance. Staying below your therapeutic dose may limit long-term results, but your provider's recommendation depends on your individual response and any side effects you experience.
How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?
Yes. The Precision Peptide Genetic Test examines variants in GIPR and MC4R, and FTO genes that influence how quickly you feel full, how much nausea you experience, and how effectively semaglutide suppresses your appetite at each dose level. This $298 test helps your provider anticipate whether you will tolerate the standard four-week escalation schedule or need a modified timeline.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Nausea on Wegovy: What You Can Take for Relief and Support
How Effective is Wegovy for Weight Loss: A Comprehensive Overview